Dermata Therapeutics annual operating expenses
2020
2021
2022
2023
2024
2025
Dermata Therapeutics Operating Expenses Growth & History (DRMA)
Dermata Therapeutics's operating expenses was $7.8M for fiscal 2025.
View full Dermata Therapeutics company overviewDermata Therapeutics annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $7.8M | −$4.7M | −37.88% |
| 2024 | 2024-12-31 | $12.5M | $4.5M | +55.60% |
| 2023 | 2023-12-31 | $8.0M | −$1.6M | −16.88% |
| 2022 | 2022-12-31 | $9.7M | $1.8M | +23.13% |
| 2021 | 2021-12-31 | $7.9M | $4.7M | +147.63% |
| 2020 | 2020-12-31 | $3.2M | — | — |
Dermata Therapeutics quarterly operating expenses
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.0M | $1.2M | +70.00% |
| Q1 2026 | 2026-03-31 | $1.9M | −$413,421 | −17.67% |
| Q4 2025 | 2025-12-31 | $1.9M | −$1.3M | −40.62% |
| Q3 2025 | 2025-09-30 | $1.8M | −$1.5M | −45.42% |
| Q2 2025 | 2025-06-30 | $1.8M | −$1.1M | −38.53% |
| Q1 2025 | 2025-03-31 | $2.3M | −$863,757 | −26.96% |
| Q4 2024 | 2024-12-31 | $3.2M | $980,455 | +44.17% |
| Q3 2024 | 2024-09-30 | $3.2M | $1.4M | +78.02% |
| Q2 2024 | 2024-06-30 | $2.9M | $1.2M | +66.46% |
| Q1 2024 | 2024-03-31 | $3.2M | $925,878 | +40.65% |
| Q4 2023 | 2023-12-31 | $2.2M | $508,143 | +29.69% |
| Q3 2023 | 2023-09-30 | $1.8M | −$634,094 | −25.92% |
| Q2 2023 | 2023-06-30 | $1.7M | −$998,159 | −36.55% |
| Q1 2023 | 2023-03-31 | $2.3M | −$508,470 | −18.25% |
| Q4 2022 | 2022-12-31 | $1.7M | −$841,164 | −32.95% |
| Q3 2022 | 2022-09-30 | $2.4M | $733,803 | +42.86% |
| Q2 2022 | 2022-06-30 | $2.7M | $1.4M | +105.31% |
| Q1 2022 | 2022-03-31 | $2.8M | $524,379 | +23.18% |
| Q4 2021 | 2021-12-31 | $2.6M | — | — |
| Q3 2021 | 2021-09-30 | $1.7M | $1.2M | +217.05% |
| Q2 2021 | 2021-06-30 | $1.3M | — | — |
| Q1 2021 | 2021-03-31 | $2.3M | — | — |
| Q3 2020 | 2020-09-30 | $540,062 | — | — |
Dermata Therapeutics operating expenses trends
Over the last five fiscal years, Dermata Therapeutics's operating expenses increased from $3.2M to $7.8M, a change of $4.6M. The latest reported quarter, Q2 2026, shows $3.0M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dermata Therapeutics source filings ↗